The stratospheric rise of Lemonade’s share price in its opening days raises the question of whether other InsurTechs will now rush to list on the public markets.
InsurTech
The stratospheric rise of Lemonade’s share price in its opening days raises the question of whether other InsurTechs will now rush to list on the public markets.
InsurTech